Taking on analysts’ expectations and winning: AngioDynamics Inc. (ANGO)

AngioDynamics Inc. (NASDAQ: ANGO) stock fell -2.28% on Friday to $7.30 against a previous-day closing price of $7.47. With 8.85 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.48 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $7.54 whereas the lowest price it dropped to was $7.07. The 52-week range on ANGO shows that it touched its highest point at $22.24 and its lowest point at $6.72 during that stretch. It currently has a 1-year price target of $16.50. Beta for the stock currently stands at 0.61.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ANGO was up-trending over the past week, with a rise of 2.67%, but this was down by -14.92% over a month. Three-month performance dropped to -32.72% while six-month performance fell -42.02%. The stock lost -66.61% in the past year, while it has lost -46.99% so far this year. A look at the trailing 12-month EPS for ANGO yields -1.33 with Next year EPS estimates of -0.15. For the next quarter, that number is -0.07. This implies an EPS growth rate of -95.20% for this year and 53.10% for next year. EPS is expected to grow by 15.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -29.30%.

Float and Shares Shorts:

At present, 39.61 million ANGO shares are outstanding with a float of 37.41 million shares on hand for trading. On Aug 30, 2023, short shares totaled 1.22 million, which was 3.08% higher than short shares on Jul 30, 2023. In addition to Mr. James C. Clemmer as the firm’s CEO, Pres & Director, Mr. Stephen A. Trowbridge serves as its Exec. VP & CFO.

Institutional Ownership:

Through their ownership of 88.88% of ANGO’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 59.66% of ANGO, in contrast to 48.30% held by mutual funds. Shares owned by individuals account for 45.76%. As the largest shareholder in ANGO with 16.13% of the stake, BlackRock Fund Advisors holds 6,398,165 shares worth 6,398,165. A second-largest stockholder of ANGO, The Vanguard Group, Inc., holds 2,664,522 shares, controlling over 6.72% of the firm’s shares. Dimensional Fund Advisors LP is the third largest shareholder in ANGO, holding 2,123,170 shares or 5.35% stake. With a 6.99% stake in ANGO, the iShares Core S&P Small Cap ETF is the largest stakeholder. A total of 2,772,207 shares are owned by the mutual fund manager. The Victory Sycamore Small Company Op, which owns about 2.94% of ANGO stock, is the second-largest Mutual Fund holder. It holds 1,167,000 shares valued at 9.37 million. Vanguard Total Stock Market ETF holds 2.81% of the stake in ANGO, owning 1,113,842 shares worth 8.94 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ANGO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ANGO analysts setting a high price target of $20.00 and a low target of $13.00, the average target price over the next 12 months is $16.50. Based on these targets, ANGO could surge 173.97% to reach the target high and rise by 78.08% to reach the target low. Reaching the average price target will result in a growth of 126.03% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded ANGO stock several times over the past three months with 14 Buys and 22 Sells. In these transactions, 304,129 shares were bought while 22,447 shares were sold. The number of buy transactions has increased to 16 while that of sell transactions has risen to 26 over the past year. The total number of shares bought during that period was 315,212 while 30,172 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *